Ares Management Corporation just posted its June 8 results, gained nearly 4% on the day, and yet short sellers responded by pressing harder — a tension that defines where the stock sits heading into the summer.
Short interest tells a story of persistent and accelerating conviction on the bear side. At 8.35% of the free float, it has climbed 11% in a week and 25% over the past month — the sharpest sustained build in the trailing 30-day window. The ORTEX short score hit 58.6 on June 9, its highest reading in the dataset, continuing a grind that began around 51 in late May. That said, the borrow market hasn't tightened enough to create mechanical pressure. Cost to borrow has edged up to 0.65%, about 19% above where it was a month ago, but remains cheap in absolute terms — shorts carry the position at minimal cost. Availability has narrowed from above 650% in early May to 286% now, which is tighter than it was but still firmly in the range where a forced-cover event is a distant prospect. Shorts are building cheaply, with room to keep building. Options, meanwhile, are running near their 20-day average: the put/call ratio of 1.16 is slightly below that mean and well within a standard deviation — no obvious call of caution or enthusiasm from derivatives traders.
The Street, broadly speaking, remains constructive. Most recent analyst activity has involved trimming price targets rather than changing ratings, with a cluster of Overweight and Buy calls intact even after cuts. TD Cowen lowered to $144 in mid-May while keeping its Buy. Oppenheimer came down a point to $146, also maintaining Outperform. Barclays actually raised its target to $140 after the May 4 results. JP Morgan holds Overweight but cut to $144 from $188 in late April — a large reset on valuation that reflects the broader de-rating in the sector. The consensus mean target is $145, implying roughly 11% upside to the current $130.61. The earnings growth scorecard looks strong on a forward 12-month basis, ranking in the 91st percentile for projected EPS increase — but near-term momentum is softer, with the 90-day EPS revision score in the 21st percentile. The bull case rests on AUM growth, institutional demand for alternatives, and the earnings power of a diversified credit platform. The bear case centres on potential multiple compression, private credit risks, and the stock's premium price-to-book of 6.7x.
On the institutional side, the most notable recent move is Wellington Management adding over 5.3 million shares, bringing its position to 11.2 million shares (roughly 5% of outstanding). Capital Research also added 2.96 million shares in May, now at 6.6%. These are sizable additions from active managers, and they sit in interesting contrast to the simultaneous build in short positions — institutional buyers and short sellers are reaching different conclusions from the same fundamental picture.
The earnings record is relevant context. ARES gained 3.9% on June 8 after the Q1 release, following a 3.3% jump after its February earnings and a 2.2% gain after May 1 results. Three positive one-day reactions in a row, all running in the 2-4% range. The next event is scheduled for July 31. Whether the short build reflects a genuine fundamental thesis or a fade-the-positive-reaction trade heading into that print is the question worth tracking over the next several weeks.
See the live data behind this article on ORTEX.
Open ARES on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
